Guided Therapeutics, Inc.
OTC: GTHP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mark L. Faupel
- Employees
- 4
- Headquarters
- Norcross, United States
- IPO year
- 2021
- Market cap
- $19.9M
- Website
- https://www.guidedinc.com
Loading GTHP…
Loading profile data…Frequently asked questions about GTHP
What does Guided Therapeutics, Inc. (GTHP) do?
Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer. This technology excels at identifying both cancerous and precancerous conditions of the cervix in a painless, n...
Where does GTHP trade?
Guided Therapeutics, Inc. (GTHP) trades on the Other OTC.
What sector is GTHP in?
Guided Therapeutics, Inc. (GTHP) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Guided Therapeutics, Inc.?
Mark L. Faupel is the chief executive officer of Guided Therapeutics, Inc. (GTHP).
Where is Guided Therapeutics, Inc. headquartered?
Guided Therapeutics, Inc. is headquartered in United States.
Does GTHP pay a dividend?
Guided Therapeutics, Inc. (GTHP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GTHP go public?
Guided Therapeutics, Inc. (GTHP) completed its initial public offering in 2021.